Comparison of 3 severity criteria for Clostridium difficile infection

Infection Control and Hospital Epidemiology

Volumn 35, Issue 2, 2014, Pages 196-199

  Gomez Simmonds, Angela ^a   Kubin, Christine J ^a   Furuya, E Yoko ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CLASSIFICATION; COMPARATIVE STUDY; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

AGED; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84892705917     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/674851     Document Type: Article

References (10)

1. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-262.
2. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Eng J Med 2005;353:2433-2441.
3. Warny M, Pepin J, Fang A, et al. Increased toxins A and B production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-1084.
4. Musher DM, Aslam S, Logan N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586-1590.
5. Pepin, J, Alary ME, Valiquette L et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40;1591-1597.
6. Belmares J, Gerding DN, Parada JP, et al. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect 2007;55:495-501.
7. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302-307.
8. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31;431-455.
9. Guidelines for the management of Clostridium difficile-associated disease (CDAD) in adult patients. Joint Subcommittee on Anti-Infective Use website. http://www.id.hs.columbia.edu /documents/Clinical%20References/Clostridium_Difficile_Guidelines_11-10-09.pdf. Published 2007. Accessed March 11, 2010.
10. Bloomfield MG, Sherwin JC, Gkrania-Klotsas E. Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review. J Hosp Infect 2012;82:1-12.